5 Fascinating Insights From a Top Psychedelics Researcher
Dr. Matthew Johnson, one of the most published psychedelics researchers in the world, shares two decades worth of wisdom.
Author: Greg Gilman
New Study Determines Psilocybin Provides ‘Rapid and Sustained Antidepressant Effect’
One of the largest studies yet lends more evidence to the view that psilocybin “may hold promise as a novel intervention for major depressive disorder.”
‘Psilocybin Has Been Extremely Effective’: Firefighter Advocates for Decriminalization
“There are countless first responders, veterans and people across California who could benefit,” says a retired New York City fireman.
Psilocybin v. Escitalopram: Study Compares Effects on Depression
Researchers probe treating one of the greatest psychological issues of our time with two different drugs.
Psychedelic Business Spotlight – May 27
This week in psychedelic business news: New patents; another Health Canada SAP Approval; and legal psilocybin rules for Oregon.
Psychedelic Business Spotlight – May 20
This week in psychedelic business news: Another psychedelic merger; an Optimi Health acquisition; and good news for alcohol abuse treatment.
COVID-19 on Mushrooms: A Psilocybin Trip Report
I finally caught the bug, and after a mild bout with the Coronavirus, I ate 3.7 grams of mushrooms during my final weekend of quarantine.
Psychedelic Business Spotlight – May 13
This week in psychedelic business news: Beckley Retreats set launch; another shark swims into the psychedelics industry; and MindMed shares promising LSD study results.
Psychedelic Business Spotlight – May 6
This week in psychedelic business news: Wesana Health pivots strategy; Compass Pathways makes progress on anorexia; Completion launches psychedelic VR NFTs.
Compass Pathways Shares ‘Promising’ Data That Psilocybin May Treat Anorexia
There is currently no FDA-approved treatment for anorexia. Could psychedelics be the answer?
End of content
End of content